Search

Author/Creator Enzmann, Harald

21. The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation. (10th March 2020)

Authors:
Tzogani, Kyriaki; Røshol, Hilde; Olsen, Helga Haugom; Aas, Ida B.; Dalhus, Marianne Løiten; Håkonsen, Gro Dahlseng; Nilssen, Laila Sortvik; Lindberg, Vibeke; Økvist, Mats; Bolstad, Bjørg; Rogovska, Irēna; Karpova, Natalja; Enzmann, Harald; Gisselbrecht, Christian; Pignatti, Francesco
Journal:
Oncologist
Issue:
Volume 25:Number 7(2020)
Page Start:
e1070
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Sideroblasts or Beta-thalassemia. Issue 8 (19th August 2021)

Authors:
Delgado, Julio; Voltz, Caroline; Stain, Milena; Balkowiec-Iskra, Ewa; Mueller, Brigitte; Wernsperger, Johanna; Malinowska, Iwona; Gisselbrecht, Christian; Enzmann, Harald; Pignatti, Francesco
Journal:
HemaSphere
Issue:
Volume 5:Issue 8(2021)
Page Start:
e616
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma. Issue 12 (18th December 2021)

Authors:
Delgado, Julio; Papadouli, Irene; Sarac, Sinan B.; Moreau, Alexandre; Hovgaard, Doris; Gisselbrecht, Christian; Enzmann, Harald; Pignatti, Francesco
Journal:
HemaSphere
Issue:
Volume 5:Issue 12(2021)
Page Start:
e666
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗